Monopoly Claims Nixed In Solodyn Pay-For-Delay Suit
A Massachusetts federal judge on Friday pared down multidistrict litigation accusing Medicis Pharmaceutical Corp. of paying off several generic drugmakers to delay launching their own versions of acne medication Solodyn, but...To view the full article, register now.
Already a subscriber? Click here to view full article